Evidence map›Paper›PMID 37273158›Full record

ArticleJournal of epidemiology and global health2023

Recurrent Urinary Tract Infection in Adult Patients, Risk Factors, and Efficacy of Low Dose Prophylactic Antibiotics Therapy.

Hala Alghoraibi, Aisha Asidan, Raneem Aljawaied, Raghad Almukhayzim, Aljoharah Alsaydan, Elaf Alamer, Waleed Baharoon, Emad Masuadi, Abeer Al Shukairi, Laila Layqah and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of epidemiology and global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. DistinctbioRxiv : the preprint server for biology · 2024
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Hala AlghoraibiCollege of Medicine, King Saud Ibn Abdulaziz University for Health and Sciences, Riyadh, Saudi Arabia.
Aisha AsidanCollege of Medicine, King Saud Ibn Abdulaziz University for Health and Sciences, Riyadh, Saudi Arabia.
Raneem AljawaiedCollege of Medicine, King Saud Ibn Abdulaziz University for Health and Sciences, Riyadh, Saudi Arabia.
Raghad AlmukhayzimCollege of Medicine, King Saud Ibn Abdulaziz University for Health and Sciences, Riyadh, Saudi Arabia.
Aljoharah AlsaydanCollege of Medicine, King Saud Ibn Abdulaziz University for Health and Sciences, Riyadh, Saudi Arabia.
Elaf AlamerCollege of Medicine, King Saud Ibn Abdulaziz University for Health and Sciences, Riyadh, Saudi Arabia.
Waleed BaharoonKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Emad MasuadiCollege of Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.
Abeer Al ShukairiDepartment of Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia.
Laila LayqahKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Salim BaharoonDepartment of Intensive Care, King Abdulaziz Medical City, Riyadh, Saudi Arabia. Baharoon@Hotmail.com.
King Abdullah International Medical Research Center · SAKing Saud bin Abdulaziz University for Health Sciences · SANational Guard Health Affairs · SAKing Abdulaziz Medical City · SAKing Faisal Specialist Hospital & Research Centre · SAUnited Arab Emirates University · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecurrent urinary tract infection (UTI) occurs in sizable percentages of patients after a single episode and is a frequent cause of primary healthcare visits and hospital admissions, accounting for up to one quarter of emergency department visits. We aim to describe the pattern of continuous antibiotic prophylaxis prescription for recurrent urinary tract infections, in what group of adult patients they are prescribed and their efficacy.

methodsA retrospective chart review of all adult patients diagnosed with single and recurrent symptomatic urinary tract infection in the period of January 2016 to December 2018.

resultsA total of 250 patients with a single UTI episode and 227 patients with recurrent UTI episodes were included. Risk factors for recurrent UTI included diabetes mellitus, chronic renal disease, and use of immunosuppressive drugs, renal transplant, any form of urinary tract catheterization, immobilization and neurogenic bladder. E. coli infections were the most prevalent organism in patients with UTI episodes. Prophylactic antibiotics were given to 55% of patients with UTIs, Nitrofurantoin, Bactrim or amoxicillin clavulanic acid. Post renal transplant is the most frequent reason to prophylaxis antibiotics (44%). Bactrim was more prescribed in younger patients (P < 0.001), in post-renal transplantation (P < 0.001) and after urological procedures (P < 0.001), while Nitrofurantoin was more prescribed in immobilized patients (P = 0.002) and in patients with neurogenic bladder (P < 0.001). Patients who received continuous prophylactic antibiotics experienced significantly less episodes of urinary tract infections (P < 0.001), emergency room visits and hospital admissions due to urinary tract infections (P < 0.001).

conclusionDespite being effective in reducing recurrent urinary tract infection rate, emergency room visits and hospital admissions due to UTI, continuous antibiotic prophylaxis was only used in 55% of patients with recurrent infections. Trimethoprim/sulfamethoxazole was the most frequently used prophylactic antibiotic. Urology and gynecological referral were infrequently requested as part of the evaluation process for patients with recurrent UTI. There was a lack of use of other interventions such as topical estrogen in postmenopausal women and documentation of education on non-pharmacological methods to decrease urinary tract infections.

Indexed as

Escherichia coli InfectionsUrinary Bladder, NeurogenicUrinary Tract InfectionsAdultAnti-Bacterial AgentsAntibiotic ProphylaxisEscherichia coliFemaleHumansNitrofurantoinRetrospective StudiesRisk FactorsTrimethoprim, Sulfamethoxazole Drug CombinationAnti-Bacterial AgentsNitrofurantoinTrimethoprim, Sulfamethoxazole Drug CombinationAntibiotic prophylaxisNitrofurantoinRecurrent urinary tract infectionRisk factorsTMP-SMXUrinary tract infection

Identifiers

PMID37273158
PMCPMC10271986
OpenAlexW4379376859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.